197 related articles for article (PubMed ID: 31802036)
1. GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Guo Y; Yuan X; Li K; Dai M; Zhang L; Wu Y; Sun C; Chen Y; Cheng G; Liu C; Strååt K; Kong F; Zhao S; Bjorkhölm M; Xu D
Cell Death Differ; 2020 Jun; 27(6):1862-1877. PubMed ID: 31802036
[TBL] [Abstract][Full Text] [Related]
2. GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Yuan X; Mu N; Wang N; Strååt K; Sofiadis A; Guo Y; Stenman A; Li K; Cheng G; Zhang L; Kong F; Ekblad L; Wennerberg J; Nilsson IL; Juhlin CC; Larsson C; Xu D
Oncogene; 2019 Feb; 38(7):965-979. PubMed ID: 30181547
[TBL] [Abstract][Full Text] [Related]
3. TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends.
Yuan X; Dai M; Xu D
Cancer Lett; 2020 Nov; 493():1-9. PubMed ID: 32768523
[TBL] [Abstract][Full Text] [Related]
4. GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma.
Fang Z; Zhang N; Yuan X; Xing X; Li X; Qin X; Liu Z; Neo S; Liu C; Kong F; Björkholm M; Fan Y; Xu D
J Exp Clin Cancer Res; 2022 May; 41(1):173. PubMed ID: 35549739
[TBL] [Abstract][Full Text] [Related]
5. Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features.
Xing X; Mu N; Yuan X; Wang N; Juhlin CC; Strååt K; Larsson C; Neo SY; Xu D
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326537
[TBL] [Abstract][Full Text] [Related]
6. TERT promoter alterations could provide a solution for Peto's paradox in rodents.
Vedelek B; Maddali AK; Davenova N; Vedelek V; Boros IM
Sci Rep; 2020 Nov; 10(1):20815. PubMed ID: 33257697
[TBL] [Abstract][Full Text] [Related]
7. TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.
Min J; Shay JW
Cancer Discov; 2016 Nov; 6(11):1212-1214. PubMed ID: 27807101
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Stern JL; Theodorescu D; Vogelstein B; Papadopoulos N; Cech TR
Genes Dev; 2015 Nov; 29(21):2219-24. PubMed ID: 26515115
[TBL] [Abstract][Full Text] [Related]
9. Argininosuccinate lyase drives activation of mutant TERT promoter in glioblastomas.
Shi Z; Ge X; Li M; Yin J; Wang X; Zhang J; Chen D; Li X; Wang X; Ji J; You Y; Qian X
Mol Cell; 2022 Oct; 82(20):3919-3931.e7. PubMed ID: 36270249
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.
Mancini A; Xavier-Magalhães A; Woods WS; Nguyen KT; Amen AM; Hayes JL; Fellmann C; Gapinske M; McKinney AM; Hong C; Jones LE; Walsh KM; Bell RJA; Doudna JA; Costa BM; Song JS; Perez-Pinera P; Costello JF
Cancer Cell; 2018 Sep; 34(3):513-528.e8. PubMed ID: 30205050
[TBL] [Abstract][Full Text] [Related]
11. TERT and its binding protein: overexpression of GABPA/B in high grade gliomas.
Papazacharias E; Kuhl S; Röhn G; Görtz L; Goldbrunner R; Timmer M
Oncotarget; 2021 Jun; 12(13):1271-1280. PubMed ID: 34194624
[TBL] [Abstract][Full Text] [Related]
12.
Zhang T; Xu M; Makowski MM; Lee C; Kovacs M; Fang J; Willems E; Trent JM; Hayward NK; Vermeulen M; Brown KM
Cancer Res; 2017 Apr; 77(7):1649-1661. PubMed ID: 28108517
[No Abstract] [Full Text] [Related]
13. GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
Zhang S; Zhang K; Ji P; Zheng X; Jin J; Feng M; Liu P
BMC Cancer; 2017 May; 17(1):380. PubMed ID: 28549418
[TBL] [Abstract][Full Text] [Related]
14. PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.
Liu JY; Qian D; He LR; Li YH; Liao YJ; Mai SJ; Tian XP; Liu YH; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
Mol Cancer; 2013 Nov; 12(1):148. PubMed ID: 24268029
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression.
Beck S; Jin X; Sohn YW; Kim JK; Kim SH; Yin J; Pian X; Kim SC; Nam DH; Choi YJ; Kim H
Mol Cells; 2011 Jan; 31(1):9-15. PubMed ID: 21193962
[TBL] [Abstract][Full Text] [Related]
16. Cancer-specific loss of
Amen AM; Fellmann C; Soczek KM; Ren SM; Lew RJ; Knott GJ; Park JE; McKinney AM; Mancini A; Doudna JA; Costello JF
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33758097
[TBL] [Abstract][Full Text] [Related]
17. Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites.
Vaughan CA; Deb SP; Deb S; Windle B
Oncotarget; 2014 Jan; 5(2):417-27. PubMed ID: 24481480
[TBL] [Abstract][Full Text] [Related]
18. Hyperpolarized δ-[1-
Minami N; Hong D; Taglang C; Batsios G; Gillespie AM; Viswanath P; Stevers N; Barger CJ; Costello JF; Ronen SM
Sci Rep; 2023 Mar; 13(1):5190. PubMed ID: 36997627
[TBL] [Abstract][Full Text] [Related]
19. Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma.
Minami N; Hong D; Stevers N; Barger CJ; Radoul M; Hong C; Chen L; Kim Y; Batsios G; Gillespie AM; Pieper RO; Costello JF; Viswanath P; Ronen SM
Neuro Oncol; 2022 Nov; 24(11):1898-1910. PubMed ID: 35460557
[TBL] [Abstract][Full Text] [Related]
20. GA-Binding Protein Alpha Is Involved in the Survival of Mouse Embryonic Stem Cells.
Ueda A; Akagi T; Yokota T
Stem Cells; 2017 Nov; 35(11):2229-2238. PubMed ID: 28762569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
